Mike Sherman is an application engineering leader on 3M’s Commercial Solutions Division (CSD) team. During the pandemic, Mike and his team have helped their customers solve challenges like finding the right disinfectants to use against SARS-CoV-2, the virus that causes COVID-19, or developing robust graphic solutions to illustrate social distancing guidelines.
As SARS-CoV-2 moves fast through our global population, the pharmaceutical industry faces tremendous pressure to move even faster.
Press Release
March, 2020 - /3BL Media/ - Industry leaders are jousting with questions of how to quickly evaluate new and repurposed drugs while simultaneously readying their operations for rapid transformation. Novel partnerships between private R&D teams and public health agencies are emerging to address the “discovery” half of that equation, which leaves company leaders to grapple with the other half: how can they prepare their operations for commercial-scale manufacturing of a therapy that hasn’t yet been identified or approved?
